Skip to main content
Premium Trial:

Request an Annual Quote

Waters, Tecan Partner on Clinical Assay Platform

NEW YORK (GenomeWeb News) – Waters today announced an agreement with the Tecan Group to automate sample preparation in order to improve clinical assays developed on liquid chromatography/mass spectrometry technologies.

The deal calls for the combination of Water's Acquity TQD LC/MS systems with Tecan's Freedom EVO liquid handling platform into a single fully supported analytical system solution "that helps laboratories increase assay throughput and efficiency, improve profitability, and drive down overall assay costs," Waters said in a statement.

In its own statement, Tecan said it expects the integrated instrument to be available within the next six months.

Financial terms of the deal were not disclosed.

According to Patrick Martell, clinical marketing director for Waters, the multi-step process of preparing samples for LC/MS/MS analyses is a major bottleneck and laboratory managers consistently have asked for better and more automated sample preparation and analysis.

"Combining sample preparation and analysis in a single unified platform facilitates the entire assay process and streamlines analyses significantly," he said. "By lowering assay costs and bringing a greater consistency to test results, laboratories can offer clients a higher level of service and responsiveness."

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.